Skip to main content
All lobbying clients

VERTEX PHARMACEUTICALS INCORPORATED

Lobbying client · Massachusetts · filed 2025 to 2026

$7,300,000 Reported spend
6 Filings counted
1 Firms hired
6 Bills named

Spend is reported income plus in-house expenses across 6 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (188223), not by name.

 Firms hired 1
 Bills named in these filings 6
  • HR 1227
    Alternatives to PAIN Act
    6 filings
  • S 475
    Alternatives to PAIN Act
    6 filings
  • S 864
    HELP Copays Act
    6 filings
  • HR 1414
    Cameron’s Law
    5 filings
  • HR 6423
    HELP Copays Act
    3 filings
  • HR 1518
    New Era of Preventing End-Stage Kidney Disease Act
    2 filings
 Reported by year 2 years
  • 2026 $2,340,000 2 filings
  • 2025 $4,960,000 4 filings
 Issues lobbied 9

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 13
  • Centers For Medicare and Medicaid Services (CMS) 6
  • Congressional Budget Office (CBO) 6
  • HOUSE OF REPRESENTATIVES 6
  • Office of Management & Budget (OMB) 6
  • SENATE 6
  • White House Office 6
  • Food & Drug Administration (FDA) 5
  • Health & Human Services, Dept of (HHS) 4
  • U.S. Trade Representative (USTR) 4
  • Vice President of the U.S. 4
  • Commerce, Dept of (DOC) 2
  • Patent & Trademark Office (PTO) 1
  • State, Dept of (DOS) 1

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem